Loading…
US stock · US markets · public data
BIIB
Biogen Inc · Healthcare
Reference price$227.60Updated according to the public source
P/E40.72
P/B1.78
ROE4.58%
DY 12M0.00%
Net margin—
Debt/equity—
Market capUS$ 33.6 B
Volume (shares)940,078
SectorHealthcare
Overview
Demonstrações públicas consolidadas + SEC Company FactsAbout BIIB
Biogen Inc (BIIB) is a stock traded in US markets in the Healthcare sector. P/E 40.72, P/B 1.78, ROE 4.58% and dividend yield 0.00%. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
AvailableIncome statement, balance sheet and cash flow
Account2006200720082009
Revenue—3,171,617,0004,097,507,0004,377,348,000
Gross Profit———3,995,200,000
Operating Income—779,772,0001,213,611,0001,295,427,000
Net Income—638,172,000783,167,000970,132,000
EPS Diluted—233
FAQ
Frequently asked questions
What is the price of BIIB?
The current price of BIIB is $227.60.
What is the P/E of BIIB?
The P/E ratio of BIIB is 40.72, meaning investors pay 40.72 times earnings per share.
What is the P/B of BIIB?
The P/B of BIIB is 1.78, meaning the stock trades at 1.78 times its book value per share.
What is the ROE of BIIB?
The ROE (Return on Equity) of BIIB is 4.58%, meaning the company generates 4.58% of profit for every unit of shareholders' equity.
What is the dividend yield of BIIB?
The dividend yield of BIIB is 0.00%. This represents the annual dividend relative to the current share price.
What is the market cap of BIIB?
The market capitalization of BIIB is US$ 33.6 B.
What sector is BIIB in?
BIIB operates in the Healthcare sector.